Endovascular stent implantation for treatment of peripheral artery disease

European Journal of Clinical Investigation

Volumn 37, Issue 3, 2007, Pages 165-170

  Schillinger, M ^a,b   Minar, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL;

ARTERY DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; LEG REVASCULARIZATION; LIMB BLOOD VESSEL; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STENT; TREATMENT FAILURE; TREATMENT PLANNING; VASCULAR PATENCY;

BALLOON DILATATION; HUMANS; ILIAC ARTERY; LEG; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; STENTS; TREATMENT OUTCOME;

EID: 33847209270     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01774.x     Document Type: Review

References (32)

1. Maca T, Ahmadi R, Derfler K, Horl WH, Koppensteiner R, Minar E et al. Elevated lipoprotein (a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? Atherosclerosis 1996;127:27-34.
2. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 1984;70:619-23.
3. Krepel VM, van Andel GJ, van Erp WF, Breslau PJ. Percutaneous transluminal angioplasty of femoropopliteal artery: initial and long-term results. Radiology 1985;156:325-8.
4. Cejna M, Thurnher SA, Illiasch H, Horvath W, Waldenberger P, Hornik K et al. PTA vs Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomised study. J Vasc Interven Radiol 2001;12:23-31.
5. Exner M, Schillinger M, Minar E, Mlekusch W, Schlerka G, Haumer M et al. Heme oxygenase-1 microsatellite gene promoter polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther 2001;8:433-40.
6. Schillinger M, Haumer M, Schlerka G, Mlekusch W, Exner M, Ahmadi R et al. Restenosis after percutaneous transluminal angioplasty in patients with peripheral artery disease: the role of inflammation. J Endovasc Ther 2001;8:477-83.
7. Minar E, Pokrajac B, Ahmadi R, Maca T, Seitz W, Stumpflen A et al. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study. Radiology 1998;208:173-9.
8. Treiman GS, Schneider PA, Lawrence PF, Pevec WC, Bush RL, Ichikawa L. Does stent placement improve the results of ineffective or complicated iliac artery angioplasty? J Vasc Surg 1998;28:104-12.
9. Tetteroo E, van der Graaf Y, Bosch JL, van Engelen AD, Hunink MG, Eikelboom BC et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 1998;351:1153-9.
10. Klein WM, van der Graaf Y, Seegers J, Spithoven JH, Buskens E, van Baal JG et al. Dutch Iliac Stent Trial: long-term results in patients randomized for primary or selective stent placement. Radiology 2006;238:734-44.
11. Beattie GC, Brittenden J, Gillespie I, McBride K, McInnes G, Bradbury AW. Vascular surgical society of Great Britain and Ireland: outcome of iliac percuteanous transluminal angioplasty with and without the use of stents in patients with intermittent claudication. Br J Surg 1999;86:704-5.
12. Bosch JL, Tetteroo E, Mali WP, Hunink MG. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiol 1998;208:641-8.
13. Ponec D, Jaff MR, Swischuk J, Feiring A, Laird J, Mehra M et al. CRISP Study Investigators. The nitinol SMART stent vs. Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol 2004;15:911-8.
14. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
15. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-71.
16. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 2000;102:2694-9.
17. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83:I70-80.
18. Henry M, Amor M, Beyar I, Henry I, Porte JM, Mentre B et al. Clinical experience with a new nitinol self-expanding stent in peripheral artery disease. J Endovasc Surg 1996;3:369-79.
19. Vroegineweij D, Vos LD, Tielbeek AV, Buth J, vd Bosch HC. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol 1997;20:420-5.
20. Grimm J, Muller-Hulsbeck S, Jahnke T, Hilbert C, Brossmann J, Heller M. Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Intervent Radiol 2001;12:935-42.
21. Zdanowski Z, Albrechtsson U, Lundin A, Jonung T, Ribbe E, Thorne J et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 1999;18:251-5.
22. Becquemin JP, Favre JP, Marzelle J, Nemoz C, Corsin C, Leizorovicz A. Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomised study. J Vasc Surg 2003;37:487-94.
23. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-months results. Circulation 2002;106:1505-9.
24. Sabeti S, Amighi J, Ahmadi R, Minar E, Schillinger M. Outcome of long-segment femoropopliteal stent implantation using self-expanding nitinol stents. J Endovasc Ther 2005;12:6-12.
25. Lugmayr HF, Holzer H, Kastner M, Riedelsberger H, Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology 2002;222:37-43.
26. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R et al. Patency of nitinol vs. Wallstents in the superficial femoral artery - a propensity score adjusted analysis. Radiology 2004;232:516-21.
27. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeck A et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-8.
28. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Schlager O et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88.
29. Krankenberg H for the FAST Investigators. Femoral artery stenting trial - 12 months final analysis. Transcatheter Cardiovascular Therapies - TCT. Washington D.C. October 2006. Available at www.tctmd.com.
30. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF et al. Bypass surgery versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-34.
31. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.
32. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E et al. Stenting of the superficial femoral artery - the dark sides: restenosis, clinical deterioration and fractures. J Endovasc Ther 2005;12:676-84.